Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00628927 · ClinicalTrials.gov registry record
An Eval of Neurocognitive Function, Oxidative Damage, and Their Association With Outcomes in METH and Cocaine Abusers.
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 217
- Enrollment target
NCT00628927 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 217 participants.
The verdict
NCT00628927 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 217 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether performance on neurocognitive measures predicts treatment outcomes in individuals with substance abuse disorders. A second purpose is to compare the risk of damage, as well as actual damage, to DNA and other cell parts in people with substance abuse disorders to that of people who do not have substance abuse disorders.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00628927
The ClinicalTrials.gov registry entry for NCT00628927 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 217 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00628927 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00628927 about?
NCT00628927 is a clinical study titled "An Eval of Neurocognitive Function, Oxidative Damage, and Their Association With Outcomes in METH and Cocaine Abusers.". The purpose of this study is to determine whether performance on neurocognitive measures predicts treatment outcomes in individuals with substance abuse disorders. A second purpose is to compare the risk of damage, as well as actual damage, to DNA and other cell parts in people with substance abuse ...
What is the current status of trial NCT00628927?
This trial is currently completed. The enrollment target is 217 participants. The study started on 2008-02. Estimated completion is 2010-03.
Who is sponsoring clinical trial NCT00628927?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.